Telix Pharmaceuticals Ltd. (TLX)
11.21
+0.20
(+1.82%)
USD |
NASDAQ |
Oct 09, 13:22
Telix Pharmaceuticals Net Income (Quarterly)
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 11.82M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Mesoblast Ltd. | -- |
| Immutep Ltd. | -- |
| CSL Ltd. | -- |
| Ceryvyn Therapeutics Ltd. - ADR | -- |
| Propanc Biopharma, Inc. | -4.573M |
Net Income (Quarterly) Related Metrics
| Enterprise Value | 3.673B |
| Earnings Yield | 0.83% |
| Normalized Earnings Yield | 0.4871 |